MRI-based radiomic features for identifying recurrent prostate cancer after proton radiation therapy.
Kazim Ziya GumusSamuel Serrano ContrerasMohammed Al-ToubatIra HarmonMauricio HernandezSavas OzdemirSindhu KumarNurcan YurukMutlu MeteK C BalajiMark BandykDheeraj R GopireddyPublished in: Journal of applied clinical medical physics (2024)
Our proof-of-concept study demonstrates the potential of using radiomic features as part of the differential diagnosis of PCa on mpMRI following proton therapy. The results need to be validated in a larger cohort.